Thomas Ebensen

Department of Vaccinology and Applied Microbiology, Helmholtz Centre for Infection Research

Affiliated withHelmholtz Centre for Infection Research

Research Area

Biography

Thomas Ebensen has not added Biography.
If you are Thomas Ebensen and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 2	Year
Publication title Cited by 3	2018
Publication title Cited by 23	2020

Other Publications

Article	Year
Intranasal vaccination with recombinant outer membrane protein CD and adamantylamide dipeptide as the mucosal adjuvant enhances pulmonary clearance of Moraxella catarrhalis in an experimenta... Infection and immunity\| PubMed ID: 17101651	2007
The bacterial second messenger cyclic diGMP exhibits potent adjuvant properties. Vaccine\| PubMed ID: 17187906	2007
The bacterial second messenger cdiGMP exhibits promising activity as a mucosal adjuvant. Clinical and vaccine immunology : CVI\| PubMed ID: 17567766	2007
A pegylated derivative of alpha-galactosylceramide exhibits improved biological properties. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 17675464	2007
Oral vaccination with Salmonella enterica as a cruzipain-DNA delivery system confers protective immunity against Trypanosoma cruzi. Infection and immunity\| PubMed ID: 17967857	2008
Immune modulators with defined molecular targets: cornerstone to optimize rational vaccine design. Human vaccines\| PubMed ID: 18376145	2008
A prime-boost vaccination protocol optimizes immune responses against the nucleocapsid protein of the SARS coronavirus. Vaccine\| PubMed ID: 18805454	2008
The toll-like receptor 2/6 ligand MALP-2 reduces the viability of Mycobacterium tuberculosis in murine macrophages. The open microbiology journal\| PubMed ID: 19471610	2009
Immune modulators with defined molecular targets: cornerstone to optimize rational vaccine design. Advances in experimental medicine and biology\| PubMed ID: 20047042	2009
The member of the cyclic di-nucleotide family bis-(3', 5')-cyclic dimeric inosine monophosphate exerts potent activity as mucosal adjuvant. Vaccine\| PubMed ID: 20060510	2010
Bis-(3',5')-cyclic dimeric adenosine monophosphate: strong Th1/Th2/Th17 promoting mucosal adjuvant. Vaccine\| PubMed ID: 21619907	2011
Development and characterization of attenuated metabolic mutants of Bordetella bronchiseptica for applications in vaccinology. Environmental microbiology\| PubMed ID: 22676396	2013
Vaccine adjuvants: key tools for innovative vaccine design. Current topics in medicinal chemistry\| PubMed ID: 24066891	2013
Purification of hepatitis B surface antigen virus-like particles from recombinant Pichia pastoris and in vivo analysis of their immunogenic properties. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences\| PubMed ID: 24141044	2013
A new adjuvanted nanoparticle-based H1N1 influenza vaccine induced antigen-specific local mucosal and systemic immune responses after administration into the lung. Vaccine\| PubMed ID: 24731807	2014
Intranasal delivery of influenza rNP adjuvanted with c-di-AMP induces strong humoral and cellular immune responses and provides protection against virus challenge. PloS one\| PubMed ID: 25140692	2014
Pegylated bisacycloxypropylcysteine, a diacylated lipopeptide ligand of TLR6, plays a host-protective role against experimental Leishmania major infection. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 25194056	2014
Efficient nanoparticle-mediated needle-free transcutaneous vaccination via hair follicles requires adjuvantation. Nanomedicine : nanotechnology, biology, and medicine\| PubMed ID: 25200611	2015
Inverse micellar sugar glass (IMSG) nanoparticles for transfollicular vaccination. Journal of controlled release : official journal of the Controlled Release Society\| PubMed ID: 25795506	2015
Modeling Influenza Virus Infection: A Roadmap for Influenza Research. Viruses\| PubMed ID: 26473911	2015
New Horizons in the Development of Novel Needle-Free Immunization Strategies to Increase Vaccination Efficacy. Current topics in microbiology and immunology\| PubMed ID: 27370343	2016
Self-Replicating RNA Vaccine Delivery to Dendritic Cells. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 27987142	2017
Immunization with Tc52 or its amino terminal domain adjuvanted with c-di-AMP induces Th17+Th1 specific immune responses and confers protection against Trypanosoma cruzi. PLoS neglected tropical diseases\| PubMed ID: 28234897	2017
Targeted antigen delivery to dendritic cells elicits robust antiviral T cell-mediated immunity in the liver. Scientific reports\| PubMed ID: 28266658	2017
Type I IFN and not TNF, is Essential for Cyclic Di-nucleotide-elicited CTL by a Cytosolic Cross-presentation Pathway. EBioMedicine\| PubMed ID: 28754303	2017
Bivalent mucosal peptide vaccines administered using the LCP carrier system stimulate protective immune responses against Streptococcus pyogenes infection. Nanomedicine : nanotechnology, biology, and medicine\| PubMed ID: 28887213	2017
Self-replicating RNA vaccine functionality modulated by fine-tuning of polyplex delivery vehicle structure. Journal of controlled release : official journal of the Controlled Release Society\| PubMed ID: 28935594	2017
Mucosal Administration of Cycle-Di-Nucleotide-Adjuvanted Virosomes Efficiently Induces Protection against Influenza H5N1 in Mice. Frontiers in immunology\| PubMed ID: 29033942	2017
Dual dye in-vivo imaging of differentially charged PLGA carriers reveals antigen-depot effect, leading to improved immune responses in preclinical models. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences\| PubMed ID: 29408551	2018
Influenza-Activated ILC1s Contribute to Antiviral Immunity Partially Influenced by Differential GITR Expression. Frontiers in immunology\| PubMed ID: 29623077	2018
Self-Amplifying Replicon RNA Delivery to Dendritic Cells by Cationic Lipids. Molecular therapy. Nucleic acids\| PubMed ID: 30195751	2018
The Combination Vaccine Adjuvant System Alum/c-di-AMP Results in Quantitative and Qualitative Enhanced Immune Responses Post Immunization. Frontiers in cellular and infection microbiology\| PubMed ID: 30838180	2019
Novel colloidal associations of soyasaponins and lipid components (DPPC, cholesterol) as potential adjuvants for vaccines. Vaccine\| PubMed ID: 31320217	2019
The STING activator c-di-AMP exerts superior adjuvant properties than the formulation poly(I:C)/CpG after subcutaneous vaccination with soluble protein antigen or DEC-205-mediated antigen ta... Vaccine\| PubMed ID: 31320219	2019
Invariant NKT Cell-Mediated Modulation of ILC1s as a Tool for Mucosal Immune Intervention. Frontiers in immunology\| PubMed ID: 31440243	2019
Neutral Lipopolyplexes for In Vivo Delivery of Conventional and Replicative RNA Vaccine. Molecular therapy. Nucleic acids\| PubMed ID: 31446119	2019
Mucosal CD8+ T cell responses induced by an MCMV based vaccine vector confer protection against influenza challenge. PLoS pathogens\| PubMed ID: 31525249	2019
Mucosal Heterologous Prime/Boost Vaccination Induces Polyfunctional Systemic Immunity, Improving Protection Against . Frontiers in immunology\| PubMed ID: 32153562	2020